Extended Data Fig. 3: Individual log-scaled fold change from baseline in triglycerides versus log-scaled trough concentrations of total evinacumab. | Nature Medicine

Extended Data Fig. 3: Individual log-scaled fold change from baseline in triglycerides versus log-scaled trough concentrations of total evinacumab.

From: Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial

Extended Data Fig. 3

Fold change is derived as (individual TG value at each timepoint)/(baseline TG value). Concentrations below the LLOQ were set to LLOQ/2. BLQ, below the limit of quantification; LLOQ, lower limit of quantification; N, number of patients; TG, triglyceride.

Back to article page